Inherited mutations in the gene BRCA2 predispose carriers to early onset br
east cancer, but such mutations account for fewer than 2% of all cases in E
ast Anglia. It is likely that low penetrance alleles explain the greater pa
rt of inherited susceptibility to breast cancer; polymorphic variants in st
rongly predisposing genes, such as BRCA2, are candidates for this role. BRC
A2 is thought to be involved in DNA double strand break-repair(1,2) Few mic
e in which Brca2 is truncated survive to birth; of those that do, most are
male, smaller than their normal littermates and have high cancer incidence(
3,4). Here we show that a common human polymorphism (N372H) in exon 10 of B
RCA2 confers an increased risk of breast cancer: the HH homozygotes have a
1.31-fold (95% Cl, 1.07-1.61) greater risk than the NN group. Moreover, in
normal female controls of all ages there is a significant deficiency of hom
ozygotes compared with that expected from Hardy-Weinberg equilibrium, where
as in males there is an excess of homozygotes: the HH group has an estimate
d fitness of 0.82 in females and 1.38 in males. Therefore, this variant of
BRCA2 appears also to affect fetal survival in a sex-dependent manner.